Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising -- Ignore unavailable to you. Want to Upgrade?

To: bill small who wrote (219)	5/13/1998 1:58:00 PM
From: Dr. Bob	Read Replies (1) \| Respond to of 496

Thanks, Bill. I think the taxol plans were mentioned in their annual report, too, so we're just waiting to see it get going. Couple years before any data on that, it appears. Since there's not much else to talk about...how's Maryland in May this year? - one of my favorite places to be in the Spring! Back to GLFD; looks like it's in a tight trading range of 18-22 - should work for traders, until we get an upswing. Dr. Snyder comes out with a breakthrough in pharmacology every couple years or so, though, so a major announcement could come anytime, out of the blue. My recommendation remains to hold a core position (downside risk below 18 looks very limited), and trade in the 18-22 range, if that's your game. Bob